Selective Na V 1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain.

MLA

Bankar, Girish, et al. “Selective Na V 1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain.” Cell Reports, vol. 24, no. 12, Sept. 2018, pp. 3133–45. EBSCOhost, https://doi.org/10.1016/j.celrep.2018.08.063.

APA

Bankar, G., Goodchild, S. J., Howard, S., Nelkenbrecher, K., Waldbrook, M., Dourado, M., Shuart, N. G., Lin, S., Young, C., Xie, Z., Khakh, K., Chang, E., Sojo, L. E., Lindgren, A., Chowdhury, S., Decker, S., Grimwood, M., Andrez, J.-C., Dehnhardt, C. M., … Cohen, C. J. (2018). Selective Na V 1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain. Cell Reports, 24(12), 3133–3145. https://doi.org/10.1016/j.celrep.2018.08.063

Chicago

Bankar, Girish, Samuel J Goodchild, Sarah Howard, Karen Nelkenbrecher, Matthew Waldbrook, Michelle Dourado, Noah G Shuart, et al. 2018. “Selective Na V 1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain.” Cell Reports 24 (12): 3133–45. doi:10.1016/j.celrep.2018.08.063.